Medical Billing & Technology

A publicly traded medical billing and technology company with a Hedge Fund investor was struggling to meet their derivative driven warrant obligations and SEC requirements which resulted in the company being delisted.

Clean up the financials to meet SEC standards and get the stock re-listed.  Drive sales to improve stock price to meet derivative performance requirements for warrants. 

Replaced President, CFO, and VP and Senior Vice President of Marketing and Sales. Fixed SEC and previously unknown IRS issues. Hired and trained a new Sales team.  

Result